abstract |
The present invention relates to compounds of formula 1, which can be used as active ingredients of medicaments for the prophylactic and/or therapeutic treatment of diseases caused by abnormal activation of CXCR3 chemokine. The invention further relates to processes for the preparation of the compounds, compositions comprising the compounds and novel intermediates for the preparation of the compounds. |